The 2nd Annual Pharmaceutical Congress - Pharmacon China 2017 is dedicated to issues pertaining to compliance and clinical trials in China’s pharmaceutical industry.
The 2nd Annual Pharmaceutical Congress - Pharmacon China 2017 covers topics such as:
- Clinical Trials Site Selection & Quality
- Patient Records: Quality & Validity
- Recruitment Strategies & Patient Selection
- Technologies & Other e-Clinical Trial Solution for Patients
- Best Practices on Informed Consent
- Patient Retention, Engagement & Experience
- Parmaceutical Compliance
- Financial Planning & Analysis
- Pharma Regulatory, Compliance & Legal frameworks
- Third Party Compliance Strategies
- Internal Controls & Risk Management
- Alternative Anti-Bribery Schemes & Best Practices
- Patient-centered Clinical Trials
- Sponsor-Site-CRO Relationship & Project Management in China
- CFDA Regulations, Quality Requirements & Sites
- Site Infrastructure, Capability & Shift to Electronic Systems
- Evolving Roles of PI in Trials & Investigator Initiated Trials
- Patient Support & Experience: Site Perspective & Technology